{"organizations": [], "uuid": "b9782bafe94e0b3b5ac8620d1df1d70894d1c54e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-rigel-pharmaceuticals-says-expects/brief-rigel-pharmaceuticals-says-expects-to-report-about-94-3-mln-cash-cash-equivalents-short-term-investments-as-of-march-31-2018-idUSFWN1RX0ZU", "country": "US", "domain_rank": 408, "title": "BRIEF-Rigel Pharmaceuticals Says Expects To Report About $94.3 Mln Cash, Cash Equivalents, Short-Term Investments As Of March 31, 2018", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-20T23:29:00.000+03:00", "replies_count": 0, "uuid": "b9782bafe94e0b3b5ac8620d1df1d70894d1c54e"}, "author": "", "url": "https://www.reuters.com/article/brief-rigel-pharmaceuticals-says-expects/brief-rigel-pharmaceuticals-says-expects-to-report-about-94-3-mln-cash-cash-equivalents-short-term-investments-as-of-march-31-2018-idUSFWN1RX0ZU", "ord_in_thread": 0, "title": "BRIEF-Rigel Pharmaceuticals Says Expects To Report About $94.3 Mln Cash, Cash Equivalents, Short-Term Investments As Of March 31, 2018", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-rigel pharmaceuticals says expec", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "rigel pharmaceuticals inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Market News April 20, 2018 / 8:29 PM / Updated 12 minutes ago BRIEF-Rigel Pharmaceuticals Says Expects To Report About $94.3 Mln Cash, Cash Equivalents, Short-Term Investments As Of March 31, 2018 Reuters Staff 1 Min Read \nApril 20 (Reuters) - Rigel Pharmaceuticals Inc: \n* RIGEL PHARMACEUTICALS SAYS EXPECTS TO REPORT IT HAD ABOUT $94.3 MILLION CASH, CASH EQUIVALENTS, SHORT-TERM INVESTMENTS AS OF MARCH 31, 2018 - SEC FILING Source text: ( bit.ly/2Jedbsn ) Further company coverage:", "external_links": [], "published": "2018-04-20T23:29:00.000+03:00", "crawled": "2018-04-20T23:53:25.036+03:00", "highlightTitle": ""}